Investigational Site Number 840734

Washington D.C., District of Columbia 20037

0 studies enrolling now · 1 studies all time

What they study most

Hypercholesterolaemia

Studies at this site

• Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH) — Completed